ARIA launches Precision Neurotechnologies programme with £69M for 19 teams on circuit-level brain interfaces

ARIA (UK Advanced Research and Invention Agency)/Precision Neurotechnologies Programme

ARIA announced the Precision Neurotechnologies programme with £69 million over four years, supporting 19 multidisciplinary teams to develop circuit-level, cell-type-specific brain interfaces for treating Alzheimer's, epilepsy, addiction and depression.

• Four workstreams span non-invasive interfaces, remote interfaces, biological interfaces and future adoption.
• Teams include Oxford, Rice University, Motif Neurotech and MintNeuro, united by circuit-level precision goals.
• First-year results showed early evidence that cell-type-specific neural modulation is possible.